$1.29 Billion is the total value of 683 Capital Management, LLC's 157 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 89.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COF | Buy | CAPITAL ONE FINL CORP | $41,343,300 | -11.1% | 426,000 | +0.2% | 3.21% | -3.7% |
| New | SHARKNINJA INC | $30,134,000 | – | 650,000 | +100.0% | 2.34% | – | |
| New | GE HEALTHCARE TECHNOLOGIES I | $28,917,000 | – | 425,000 | +100.0% | 2.25% | – | |
| R | Buy | RYDER SYS INC | $26,737,500 | +40.2% | 250,000 | +11.1% | 2.08% | +51.8% |
| HGV | Buy | HILTON GRAND VACATIONS INC | $22,385,001 | +18.7% | 550,000 | +32.5% | 1.74% | +28.5% |
| APLS | Buy | APELLIS PHARMACEUTICALS INCcall | $21,911,040 | -52.0% | 576,000 | +15.0% | 1.70% | -48.0% |
| XHR | Buy | XENIA HOTELS & RESORTS INC | $19,437,000 | +437.5% | 1,650,000 | +461.7% | 1.51% | +481.2% |
| NCR | New | NCR CORP NEW | $16,182,000 | – | 600,000 | +100.0% | 1.26% | – |
| VAL | Buy | VALARIS LTDcl a | $16,120,700 | +28.1% | 215,000 | +7.5% | 1.25% | +38.6% |
| Buy | NOBLE CORP PLCput | $15,195,000 | +83.9% | 300,000 | +50.0% | 1.18% | +99.2% | |
| Buy | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $14,186,550 | +47.6% | 14,750,000 | +20.4% | 1.10% | +59.9% | |
| New | PHINIA INC | $13,395,000 | – | 500,000 | +100.0% | 1.04% | – | |
| Buy | RXO INC | $12,824,500 | +59.4% | 650,000 | +83.1% | 1.00% | +72.5% | |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $11,469,500 | +8.6% | 350,000 | +16.7% | 0.89% | +17.7% |
| TGTX | New | TG THERAPEUTICS INC | $11,286,000 | – | 1,350,000 | +100.0% | 0.88% | – |
| LEN | Buy | LENNAR CORPput | $11,223,000 | +79.1% | 100,000 | +100.0% | 0.87% | +94.0% |
| GTX | New | GARRETT MOTION INC | $11,032,000 | – | 1,400,000 | +100.0% | 0.86% | – |
| QURE | Buy | UNIQURE NV | $10,568,250 | -28.8% | 1,575,000 | +21.6% | 0.82% | -22.9% |
| C | New | CITIGROUP INCput | $10,282,500 | – | 250,000 | +100.0% | 0.80% | – |
| Buy | CARDLYTICS INCnote 1.000% 9/1 | $9,775,250 | +58.3% | 16,025,000 | +45.4% | 0.76% | +71.6% | |
| C | Buy | CITIGROUP INC | $9,377,640 | +35.8% | 228,000 | +52.0% | 0.73% | +47.0% |
| CRESY | Buy | CRESUD S A C I F Y Asponsored adr | $9,366,000 | -13.4% | 1,400,000 | +0.1% | 0.73% | -6.3% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $9,327,501 | -5.4% | 2,050,000 | +46.4% | 0.72% | +2.4% |
| CZR | Buy | CAESARS ENTERTAINMENT INC NEput | $9,270,000 | +81.9% | 200,000 | +100.0% | 0.72% | +97.0% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $9,129,600 | +126.2% | 240,000 | +441.8% | 0.71% | +144.8% |
| ITOS | Buy | ITEOS THERAPEUTICS INC | $8,869,500 | +14.5% | 810,000 | +38.5% | 0.69% | +24.1% |
| SE | New | SEA LTDsponsord ads | $8,790,000 | – | 200,000 | +100.0% | 0.68% | – |
| KNOP | Buy | KNOT OFFSHORE PARTNERS LP | $7,830,602 | +58.5% | 1,146,501 | +14.7% | 0.61% | +71.5% |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCspon ads | $7,740,000 | +8.6% | 6,000,000 | +11.1% | 0.60% | +17.6% |
| FYBR | New | FRONTIER COMMUNICATIONS PARE | $7,042,500 | – | 450,000 | +100.0% | 0.55% | – |
| IFRX | Buy | INFLARX NV | $7,002,999 | -21.5% | 2,350,000 | +17.5% | 0.54% | -15.1% |
| VKTX | Buy | VIKING THERAPEUTICS INC | $6,918,750 | -26.4% | 625,000 | +7.8% | 0.54% | -20.3% |
| BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $5,638,100 | – | 65,000 | +100.0% | 0.44% | – |
| New | ARIS MNG CORP | $5,272,328 | – | 2,315,900 | +100.0% | 0.41% | – | |
| VST | New | VISTRA CORPput | $4,977,000 | – | 150,000 | +100.0% | 0.39% | – |
| NYCB | New | NEW YORK CMNTY BANCORP INCput | $4,536,000 | – | 400,000 | +100.0% | 0.35% | – |
| BWA | New | BORGWARNER INCput | $4,037,000 | – | 100,000 | +100.0% | 0.31% | – |
| New | SAREPTA THERAPEUTICS INCnote 1.250% 9/1 | $3,364,410 | – | 3,000,000 | +100.0% | 0.26% | – | |
| CLF | Buy | CLEVELAND-CLIFFS INC NEWput | $3,126,000 | +253.2% | 200,000 | +278.8% | 0.24% | +279.7% |
| MRNA | New | MODERNA INCcall | $3,098,700 | – | 30,000 | +100.0% | 0.24% | – |
| New | SOLENO THERAPEUTICS INC | $2,567,370 | – | 87,000 | +100.0% | 0.20% | – | |
| CVNA | New | CARVANA COcl a | $2,099,000 | – | 50,000 | +100.0% | 0.16% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INCput | $1,771,000 | – | 10,000 | +100.0% | 0.14% | – |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $1,776,000 | +10.3% | 1,200,000 | +20.0% | 0.14% | +19.0% |
| New | HILLEVAX INC | $1,630,140 | – | 121,200 | +100.0% | 0.13% | – | |
| GOSS | New | GOSSAMER BIO INC | $1,437,529 | – | 1,726,139 | +100.0% | 0.11% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INCcall | $1,137,500 | – | 250,000 | +100.0% | 0.09% | – |
| Buy | OMEGA THERAPEUTICS INC | $1,092,720 | -58.9% | 508,242 | +7.0% | 0.08% | -55.5% | |
| Buy | VACASA INC | $691,650 | +26.5% | 1,500,000 | +86.1% | 0.05% | +38.5% | |
| Buy | LEAP THERAPEUTICS INC | $676,200 | -29.2% | 490,000 | +60.7% | 0.05% | -23.2% | |
| IRSWS | Buy | IRSA INVERSIONES Y REP S A*w exp 05/12/202 | $652,933 | -2.8% | 1,628,261 | +1.8% | 0.05% | +6.2% |
| New | AMC ENTMT HLDGS INCcl a new | $87,890 | – | 11,000 | +100.0% | 0.01% | – | |
| New | AMC ENTMT HLDGS INCput | $87,890 | – | 100,000 | +100.0% | 0.01% | – | |
| New | FREIGHTOS LTD | $24,840 | – | 10,800 | +100.0% | 0.00% | – | |
| New | MARTI TECHNOLOGIES INC*w exp 99/99/999 | $1,810 | – | 100,000 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IRSA INVERSIONES Y REP S A | 42 | Q3 2023 | 2.9% |
| CRESUD S A C I F Y A | 39 | Q3 2023 | 3.3% |
| ENOVA INTL INC | 34 | Q3 2023 | 8.2% |
| UNIQURE NV | 28 | Q3 2023 | 4.1% |
| INSPIRED ENTMT INC | 28 | Q3 2023 | 2.3% |
| MICRON TECHNOLOGY INC | 26 | Q1 2023 | 3.2% |
| GALMED PHARMACEUTICALS LTD | 25 | Q1 2020 | 1.2% |
| FENNEC PHARMACEUTICALS INC | 25 | Q3 2023 | 0.9% |
| CARVANA CO | 24 | Q3 2023 | 14.2% |
| ALNYLAM PHARMACEUTICALS INC | 24 | Q2 2022 | 3.2% |
View 683 Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AxonPrime Infrastructure Acquisition Corp | February 14, 2023 | 441,138 | 2.9% |
| DIRTT ENVIRONMENTAL SOLUTIONS LTD | February 14, 2023 | 218,490 | - |
| Hawks Acquisition Corp | February 14, 2023 | 1,979,592 | 8.6% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2023 | 90,000 | 0.2% |
| SQZ Biotechnologies Co | February 14, 2023 | 1,330,889 | 4.5% |
| Trajectory Alpha Acquisition Corp. | February 14, 2023 | 1,484,799 | 8.6% |
| Concord Acquisition Corp | September 26, 2022 | 1,550,649 | 5.5% |
| Archer Aviation Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Hippo Holdings Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Joby Aviation, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View 683 Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View 683 Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.